drugset / Trial / NCT03464552

Celecoxib in Colposcopic Directed Biopsy

NCT03464552

Phase 4 Completed 170 enrolled Cairo University
RandomizedParallel-groupTriple-blindPrevention

Summary

Women often experience pain and discomfort during colposcopic examination especially at time of colposcopic directed excisional biopsy, pre-procedure anxiety, women pain threshold may also increase pain, woman's cooperation during the procedure is affected by all these factors, which also may hinder the colposcopist from obtaining adequate data and biopsies. Several pharmacological and non-pharmacological methods have been studied to reduce pain associated colposcopic directed biopsy (CDB). We aim to study the effect of Celecoxib to reduce pain associated with CDB.

Timeline

Start
2018-04-15
Primary completion
2019-06-30
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg Oral

Indications

No indication recorded.